Cancer Treatment Costs in Korea: What the Numbers Actually Show
Korea does not publish a single "cancer treatment cost." But specific, source-dated figures exist for major treatments — proton therapy, gastric surgery, CAR-T, and immune checkpoint inhibitors. This page organizes what is documented, what is estimated, and what remains unknown.
Quick Answer
Korea is generally less expensive than the US for cancer treatment, but not the cheapest destination in Asia. Documented figures: proton therapy full course roughly $33,000–$51,000 [citation:9], gastric cancer surgery at a major Korean hospital roughly $25,000–$30,000 for international patients (hospital-listed) [citation:11], and CAR-T therapy around $250,000–$350,000 before insurance [citation:18]. Korean national insurance pricing is far lower, but that does not apply to international patients.
Before You Compare Any Number
There are two entirely different price systems in Korea: Korean National Health Insurance rates, and international patient self-pay rates. They are not the same, and confusing them leads to unrealistic expectations.
When comparing costs, always ask: Is this the Korean insurance rate, or the international patient self-pay rate?
Proton Therapy
| Source | Reported Range | Context | Date |
|---|---|---|---|
| ChinaMedAccess | ₩45M–₩70M (~$33,000–$51,000) | Full course; 2–6 week wait | 2026-04 [citation:9] |
Korea has two operational proton therapy centers: the National Cancer Center (since 2007) and Samsung Medical Center [citation:1]. A third is under development. For comparison, proton therapy in the US typically exceeds $150,000 — Korea's documented range is significantly lower, though not as low as some claims suggest.
What to verify with the hospital: Does the quoted range include treatment planning, daily sessions, anesthesia (if pediatric), and follow-up imaging?
Gastric Cancer Surgery
| Source | Procedure | Reported Cost | Context | Date |
|---|---|---|---|---|
| Gachon University Gil Hospital (international patient page) | Partial gastrectomy | $25,000 | Hospital-listed; 10–15 day stay included | Accessed 2026 [citation:11] |
| Gachon University Gil Hospital | Total gastrectomy | $30,000 | Hospital-listed; 10–15 day stay included | Accessed 2026 [citation:11] |
| Gachon University Gil Hospital | Diagnostic tests (pre-op) | $5,700 | Separate from surgery cost | Accessed 2026 [citation:11] |
| HIRA (Korean insurance data) | Gastric cancer surgery | ₩4.7M–₩9.96M (~$3,400–$7,200) | Korean citizen reimbursement rate — not international pricing | 2026-07 [citation:1] |
Samsung Medical Center has reported strong gastric cancer outcomes — 89.5% five-year relative survival and 0.42% 90-day post-surgical mortality [citation:1] — but outcome data and cost data come from different sources and should not be conflated.
CAR-T Therapy
| Product | Reported Cost | Notes | Source |
|---|---|---|---|
| Kymriah (tisagenlecleucel) | ~₩360 million (~$260,000) list price | Reimbursed for eligible Korean patients at ~₩5.98 million out-of-pocket | Yakup News, 2026-07 [citation:16] |
| Limcarto (anbalcabtagene autoleucel) — Korea's first domestic CAR-T | Expected ~10% below Kymriah | Approved April 2026 for DLBCL/PMBCL; reimbursement pending | Chosun Ilbo, 2026-04 [citation:4] |
| General CAR-T (Korea, international patient) | $250,000–$350,000 | Base treatment cost before hospitalization and follow-up | CancerCareE CAR-T analysis, 2026 [citation:18] |
The critical distinction for international patients: Korean insurance coverage reduces out-of-pocket costs dramatically for eligible Korean citizens, but international patients generally pay the full self-pay rate. Limcarto's approval may eventually lower the market price, but reimbursement timing and international patient eligibility remain unclear.
Also important: CAR-T is not a treatment for all cancers. It is approved for specific blood cancers (certain lymphomas, leukemias, multiple myeloma) after prior treatments have failed. Eligibility depends on the exact product, indication, and line of therapy.
Immune Checkpoint Inhibitors (Example: Pembrolizumab)
Korea's reimbursement decisions for oncology drugs can shift patient costs dramatically. When pembrolizumab (Keytruda) was expanded to nine additional cancer types in 2026, the annual out-of-pocket cost for eligible Korean patients dropped from roughly ₩73 million to ₩3.65 million (~$52,000 to ~$2,600) [citation:17].
Again, this is the Korean insurance patient figure. International patients should expect to pay closer to the list price unless a specific hospital or program offers otherwise.
What This Page Does Not Tell You
No public source provides reliable, comprehensive cost data for international patients across all Korean hospitals. The figures above are directional, not quotations. Several gaps remain:
- Hospital-to-hospital variation: A major academic center and a smaller private hospital may quote very different prices for the same procedure.
- Complication costs: If surgery leads to a prolonged ICU stay or additional intervention, the final bill may exceed the initial estimate substantially.
- Medication during hospitalization: Often excluded from surgical quotes.
- Follow-up imaging and labs: Usually billed separately after discharge.
- Interpretation and international patient services: Some hospitals charge separately; others include these in the quoted price.
The only reliable number is a written, treatment-specific estimate from the hospital that will actually provide care.
What to Ask Before Accepting Any Quote
2. Does this include pre-treatment diagnostics (pathology review, imaging, molecular testing)?
3. Does this include hospitalization? How many days?
4. Does this include medications administered during the stay?
5. What happens financially if a complication occurs?
6. What follow-up visits, imaging, or labs are included after discharge?
7. Are interpretation and international patient services charged separately?
8. Is a deposit required? Is it refundable?
Related Pages
Frequently Asked Questions
Is cancer treatment in Korea cheaper than in the US?
Generally yes, for self-pay patients. Proton therapy in Korea is documented at roughly $33,000–$51,000 for a full course [citation:9], compared with $150,000+ in the US. CAR-T in Korea is estimated at $250,000–$350,000 before insurance [citation:18], compared with $373,000–$475,000 in the US. But Korea is not the cheapest option in Asia — China and India are typically lower for comparable treatments.
Why do some sources say gastric cancer surgery costs $3,400 and others say $25,000?
Because they measure different things. The ~$3,400–$7,200 figure comes from Korean National Health Insurance reimbursement data [citation:1] — what the system pays for a Korean citizen. The $25,000–$30,000 figure comes from a hospital's international patient price list [citation:11]. International patients generally pay the self-pay rate, not the insurance rate.
Does Korean health insurance cover international patients?
Generally no. Korea's National Health Insurance system covers eligible residents, not short-term international patients. Some private international insurance plans may reimburse treatment abroad, but that depends on the specific policy. Always confirm coverage with your insurer before traveling.
How much does CAR-T cost in Korea for an international patient?
Published estimates place the base treatment cost at roughly $250,000–$350,000 before hospitalization, medication, and follow-up [citation:18]. Kymriah's list price in Korea is reported at around ₩360 million (~$260,000) [citation:16]. Limcarto (Korea's domestic CAR-T, approved April 2026) is expected to be priced about 10% below Kymriah [citation:4]. Final costs depend on the center, the specific product, and whether any financial assistance is available.
Can I get a treatment cost estimate before traveling to Korea?
Yes, in most cases. Major Korean hospitals with international patient services (such as SNUH, Asan, and Samsung) typically require medical records for review before providing a treatment-specific estimate. The estimate is usually free, but the quality and detail vary by hospital. Always ask whether the quote includes diagnostics, hospitalization, medication, and follow-up.
Get a Treatment-Specific Estimate
Country-level averages are not enough. The only meaningful number is what a specific hospital will charge for a specific treatment plan. Start by defining the clinical question.